Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
LNSR
#3130
LENSAR, Inc. Common Stock
11.9
7
-0.66%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-0.66%
Changement Mensuel
-3.86%
Evolution sur 6 mois
-1.89%
Changement Annuel
+7.55%
Clôture Précédente
12.0
5
Open
11.9
7
Bid
Ask
Low
11.9
7
High
11.9
7
Volume
17
Marchés
Actions des Marchés US
Soins de Santé
LNSR
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
10.93 M
10.99 M
11.1 M
11.4 M
11.79 M
—
Valuation ratios
Enterprise value
38.66 M
34.19 M
15.64 M
25.42 M
89.14 M
526 M
Price to earnings ratio
—
—
-1.39
-3.08
-3.27
-12.11
Price to sales ratio
—
—
0.78
1.05
1.92
9.9
Price to cash flow ratio
—
—
1.87
4.59
45.26
132.08
Price to book ratio
—
—
0.66
1.33
21.18
27.47
Enterprise value to EBITDA ratio
-2.43
-2.04
-0.93
-2.91
-2.66
-13.34
Profitability ratios
Return on assets %
0.25
0.29
0.36
0.21
0.47
0.73
Return on equity %
0.29
0.36
0.47
0.43
6.46
5.3
Return on invested capital %
163.73
135.96
159.24
91.2
88.22
202.59
Gross margin %
53.35
51.75
56.44
50.06
48.33
185.37
Operating margin %
70.13
57.03
57.06
29
19.94
146.68
EBITDA margin %
-60.4
-48.7
-47.47
-20.69
-62.65
-400.92
Net margin %
74.95
56.88
56.32
34.11
58.71
343.5
Liquidity ratios
Quick ratio
5.3
4.4
1.92
2.64
2.04
4.83
Current ratio
6.9
5.14
2.95
3.99
2.8
7.38
Inventory turnover
0
0.03
0.01
0
0.01
—
Asset turnover
0.33
0.47
0.58
0.67
0.79
0.86
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
1.46
0.88
0.2
0.98
EBIT per share
—
—
-1.99
-1.11
-3.23
-5.28
EBITDA per share
—
—
-1.65
-0.8
-2.91
-4.86
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
1.44
2.19
1.95
7.2
Net current asset value per share
—
—
3.32
4.23
3.64
15.35
Tangible book value per share
—
—
2.94
2.04
-0.45
4.09
Working capital per share
—
—
2.19
3.17
2.34
6.26
Book value per share
—
—
4.13
3.05
0.42
6.38
Nouvelles
La clôture de l’accord LENSAR-Alcon repoussée au premier semestre 2026
LENSAR-Alcon deal closing pushed to first half of 2026
Lensar: Timing And Arbitrage Considerations In Alcon's Acquisition Bid (NASDAQ:LNSR)
Le BPA de LENSAR a manqué les attentes de 0,26$, le CA en dessous des prévisions
LENSAR earnings missed by $0.26, revenue fell short of estimates
LENSAR earnings missed by $0.08, revenue fell short of estimates
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019 - Alcon (NYSE:ALC)
Alcon: A Clear Vision, But Fully Valued (NYSE:ALC)
Alcon Eyes Surgical Edge With LENSAR Buyout: Details - LENSAR (NASDAQ:LNSR), Alcon (NYSE:ALC)
LENSAR stock surges 23.7% as Q4 revenue beats estimates